Unknown

Dataset Information

0

Clinically Relevant Molecular Subtypes in Leiomyosarcoma.


ABSTRACT: Leiomyosarcoma is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for leiomyosarcoma. Recognition of different molecular subtypes is necessary to evaluate novel therapeutic options. In a previous study on 51 leiomyosarcomas, we identified three molecular subtypes in leiomyosarcoma. The current study was performed to determine whether the existence of these subtypes could be confirmed in independent cohorts.Ninety-nine cases of leiomyosarcoma were expression profiled with 3'end RNA-Sequencing (3SEQ). Consensus clustering was conducted to determine the optimal number of subtypes.We identified 3 leiomyosarcoma molecular subtypes and confirmed this finding by analyzing publically available data on 82 leiomyosarcoma from The Cancer Genome Atlas (TCGA). We identified two new formalin-fixed, paraffin-embedded tissue-compatible diagnostic immunohistochemical markers; LMOD1 for subtype I leiomyosarcoma and ARL4C for subtype II leiomyosarcoma. A leiomyosarcoma tissue microarray with known clinical outcome was used to show that subtype I leiomyosarcoma is associated with good outcome in extrauterine leiomyosarcoma while subtype II leiomyosarcoma is associated with poor prognosis in both uterine and extrauterine leiomyosarcoma. The leiomyosarcoma subtypes showed significant differences in expression levels for genes for which novel targeted therapies are being developed, suggesting that leiomyosarcoma subtypes may respond differentially to these targeted therapies.We confirm the existence of 3 molecular subtypes in leiomyosarcoma using two independent datasets and show that the different molecular subtypes are associated with distinct clinical outcomes. The findings offer an opportunity for treating leiomyosarcoma in a subtype-specific targeted approach.

SUBMITTER: Guo X 

PROVIDER: S-EPMC4526352 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinically Relevant Molecular Subtypes in Leiomyosarcoma.

Guo Xiangqian X   Jo Vickie Y VY   Mills Anne M AM   Zhu Shirley X SX   Lee Cheng-Han CH   Espinosa Inigo I   Nucci Marisa R MR   Varma Sushama S   Forgó Erna E   Hastie Trevor T   Anderson Sharon S   Ganjoo Kristen K   Beck Andrew H AH   West Robert B RB   Fletcher Christopher D CD   van de Rijn Matt M  

Clinical cancer research : an official journal of the American Association for Cancer Research 20150420 15


<h4>Purpose</h4>Leiomyosarcoma is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for leiomyosarcoma. Recognition of different molecular subtypes is necessary to evaluate novel therapeutic options. In a previous study on 51 leiomyosarcomas, we identified three molecular subtypes in leiomyosarcoma. The current study was performed to determine whether the existence of these subtypes could be confirm  ...[more]

Similar Datasets

| S-EPMC5426990 | biostudies-literature
2016-12-11 | GSE85499 | GEO
| S-EPMC2820592 | biostudies-literature
| S-EPMC4012975 | biostudies-literature
| S-EPMC4351299 | biostudies-literature
| S-EPMC321763 | biostudies-literature
| S-EPMC5594508 | biostudies-literature
| S-EPMC4693300 | biostudies-literature